# Treatment of Older Adults With Acute Lymphoblastic Leukemia

> **NCT00973752** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Vincristine
- **DRUG:** Doxorubicin
- **DRUG:** PEG-asparaginase
- **DRUG:** Cytarabine
- **DRUG:** Methotrexate
- **DRUG:** Imatinib
- **DRUG:** Clofarabine
- **DRUG:** 6 Mercaptopurine

## Key facts

- **NCT ID:** NCT00973752
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2014-12
- **Final completion:** 2016-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973752, "Treatment of Older Adults With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00973752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*